UQUIFA
Shut Chinese companies hit desi pharma playersThe shakeup in Chinese factories in the wake of environmental concerns is sending shivers down the spine of the domestic drug industry, wit...
Ingen Capital sweetens Orchid Pharma offer, may acquire firmThe drug maker was among the 28 companies that the RBI mandated banks to refer to bankruptcy court by December 2017.- Vivimed acquires Uquifa for $ 55 million"In a move to bring in strategic growth into its product mix and expand the footprint in Europe and the US, the co has taken a measured str...
- Load More